About Spear Bio
The first homogeneous immunoassay platform offering unmatched sensitivity with scalable simplicity.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Founded
- 2021
- Company type
- Privately Held
Spear Bio, founded in 2021, is a well-funded and rapidly growing start-up headquartered in Woburn, Massachusetts. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar levels from sub-microliter sample volumes, enabling unprecedented sensitivity. We are dedicated to revolutionizing early disease diagnosis and monitoring, empowering clinicians and researchers to improve patient outcomes, and advance global health.
For more information, please visit www.spear.bio or email info@spear.bio.
Specialties
- Biotechnology
- Ultra Sensitive Immunoassays
- and research
Company locations
Boston, MA, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Diagnostics
- Health Care
- Biotechnology
On LinkedIn
- Followers
- 6,820
- People linked to this company
- 56
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
45,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.